Leadership and Management - Research Institute MUHC
BRaIn Theme banner
Brain management committee
The Management Committee of the Brain Repair and Integrative Neuroscience Program (BRaIN) is comprised of the program leadership and representatives from the Centre for Translational Biology (CTB), the Centre for Innovative Medicine (CIM), the Centre for Outcomes Research and Evaluation (CORE), and the Montreal Neurological Institute (MNI), as well as representatives for trainees and an external member. The committee helps shape the Brain Repair and Integrative Neuroscience (BRaIN) Program's overall structure, research priorities and vision.
The Program Management Committee includes:
Dr. Keith Murai, Program Leader
Dr. Kathy Mullen, Associate Program Leader
Dr. Marie St-Laurent, Program Manager
Yvonne Gardner, Program Assistant
Claire Gizowski, PhD/M.Sc. Representative
Dr. Alex Baldwin, Postdoctoral Fellow Representative
Dr. Derek Bowie, External Member, McGill Department of Pharmacology & Therapeutics
Dr. Guy Rouleau, Montreal Neurological Institute (MNI)
Dr. Edward A. Fon, Montreal Neurological Institute (MNI)
Dr. Reza Farivar-Mohseni, McGill Vision Research (MVR) and CTB
Dr. Lisa Koski, CIM
Dr. Christina Wolfson, CORE
Dr. Charles Bourque, Centre for Research in Neuroscience (CRN) and CTB
Dr. Marco Leyton, Department of Psychiatry and CTB
|Program Leaders and Manager|
|Keith Murai, PhD is a professor in the Department of Neurology and Neurosurgery at McGill University and is a recipient of Canada Research Chair and EJLB Scholarships. His research is focused on understanding how the brain encodes information at synapses, the intimate contact points between cells within neural circuits. Work from his research team has provided insight into cellular and molecular pathways that regulate synapses and the contribution of glial cells to brain development and function. An important goal of the research is to discover novel strategies for treating conditions where dysfunction of neural circuits occurs. Current and past leadership roles include Chair of the Montreal General Hospital Facility Animal Care Committee and Treasurer of the Canadian Association for Neuroscience. Dr. Murai's research has been published in journals such as the Journal of Neuroscience, PNAS, Journal of Cell Biology, Nature Neuroscience, Current Biology, Neuron, Cell Reports, and Cell. His work is currently supported by the Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering Research Council of Canada (NSERC), Pfizer-FRQS and Brain Canada. |
Kathy Mullen, PhD is a professor in the Department of Ophthalmology, McGill University and a founding member of the McGill Vision Research unit. Her areas of research and expertise are in human vision, specializing in colour vision and disease processes, such as multiple sclerosis, that may affect the neural aspects of vision. Her research uses functional brain imaging, brain stimulation, behavioural measurement, and computational modeling to identify the different stages along the visual pathway, from thalamus to cortex, involved in colour vision. She is a Fellow of the Optical Society of America in recognition of her contributions to vision sciences. She has taken an active role in leadership within the McGill community as a program committee member of the Integrated Program in Neuroscience (IPN). Dr. Mullen's research has been published in journals such as the Journal of Neurophysiology, Brain Stimulation, European Journal of Neuroscience, Scientific Reports, and Journal of the Optical Society of America. Her work is currently supported by the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC).
Marie St-Laurent, PhD holds a doctorate in cognitive neuroscience from the University of Toronto and brings fifteen years of experience conducting neuroscience research in Montreal and Toronto to the management of the BRaIN Program. She is well prepared to represent and advocate for the variety of scientific activities conducted in this program, having used molecular biology, lesion studies, functional brain imaging and cognitive tasks in clinical human populations.